Search Database

Name

ISIS 2503

Alternate Names

None

Abbreviations

None

Category

Other therapy

Subcategory

Antisense compound
did not receive FDA approval

NSC Number

718878

Primary Site

Breast
colorectal
lung
pancreatic cancer

Histology

None

Remarks

Phase II, Phase II NSCLC Antisense anti RAS protein. ISIS Pharmaceuticals.

Coding

This drug should be coded
Glossary